Legend Biotech Corporation
LEGN
$34.18
-$0.52-1.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.21B | 1.29B | 1.30B | 1.31B | 1.42B |
| Total Receivables | 103.98M | 101.38M | 77.96M | 157.06M | 49.69M |
| Inventory | 23.55M | 18.87M | 22.15M | 19.43M | 18.01M |
| Prepaid Expenses | 9.53M | 12.32M | 10.95M | 12.23M | 16.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 583.00K | 431.00K | 359.00K | 357.00K | 356.00K |
| Total Current Assets | 1.35B | 1.42B | 1.41B | 1.50B | 1.51B |
|
|
|||||
| Total Current Assets | 1.35B | 1.42B | 1.41B | 1.50B | 1.51B |
| Net Property, Plant & Equipment | 203.48M | 219.74M | 185.46M | 189.23M | 184.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.51M | 2.77M | 3.15M | 4.06M | 4.01M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 175.29M | 146.44M | 168.32M | 153.16M | 137.95M |
| Total Assets | 1.74B | 1.80B | 1.78B | 1.85B | 1.84B |
|
|
|||||
| Total Accounts Payable | 26.91M | 39.49M | 39.49M | 20.16M | 17.17M |
| Total Accrued Expenses | 141.22M | 132.50M | 110.49M | 105.41M | 116.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.34M | 3.33M | 3.12M | 3.18M | 2.92M |
| Total Finance Division Other Current Liabilities | 98.43M | 118.99M | 96.58M | 87.67M | 38.60M |
| Total Other Current Liabilities | 98.43M | 118.99M | 96.58M | 87.67M | 38.60M |
| Total Current Liabilities | 270.89M | 294.30M | 249.68M | 216.42M | 175.22M |
|
|
|||||
| Total Current Liabilities | 270.89M | 294.30M | 249.68M | 216.42M | 175.22M |
| Long-Term Debt | 296.62M | 291.56M | 286.40M | 281.33M | 275.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 45.63M | 44.04M | 45.17M | 44.17M | 41.69M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.58M | 9.28M | 29.80M | 55.32M | 6.88M |
| Total Liabilities | 619.72M | 639.18M | 611.05M | 597.24M | 499.70M |
|
|
|||||
| Common Stock & APIC | 2.69B | 2.68B | 2.65B | 2.64B | 2.63B |
| Retained Earnings | -1.69B | -1.56B | -1.54B | -1.48B | -1.34B |
| Treasury Stock & Other | 118.36M | 46.45M | 62.66M | 98.93M | 45.58M |
| Total Common Equity | 1.12B | 1.16B | 1.16B | 1.25B | 1.34B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.12B | 1.16B | 1.16B | 1.25B | 1.34B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.12B | 1.16B | 1.16B | 1.25B | 1.34B |
|
|
|||||
